Slow-release hydrogel aids immunotherapy for cancer – European Pharmaceutical Review
European Pharmaceutical Review |
Slow-release hydrogel aids immunotherapy for cancer
European Pharmaceutical Review An immunotherapy drug embedded in a slow-release hydrogel appears to be highly effective at killing cancer cells. STINGel combines a new class of immunotherapy drugs called stimulator of interferon gene (STING) agonists with an injectable hydrogel that … |
